Just months after saying it was phasing out an artificial hip implant because of slowing sales, a unit of Johnson & Johnson has warned doctors that the device appears to have a high early failure rate in some patients. The action by the company follows more than two years of reports that the hip implant, which is known as the ASR, was failing in patients only a few years after implant and requiring costly, painful replacement operations, the New York Times reports.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
